What cannot be promised Specific weight-loss targets, body-composition changes, or joint outcomes cannot be promised based on current evidence
People with known hypersensitivity to cobalt or cyanocobalamin should not use cyanocobalamin injection unless a clinician has evaluated the risk and chosen an appropriate plan
M., Kim, N., Yoon, H., Nam, R
inhibition explored in preclinical metabolic research Oral bioavailability demonstrated in animal models Research Status: 5-Amino-1MQ is in early preclinical stages with limited published research
AOD 9604 remains stable for 4-6 weeks when stored properly
Studies have examined NNMT inhibition in relation to cellular methylation balance, NAD metabolism, and broader metabolic signaling pathways